You are here

P&T News

October 12

Siemens Magnetom Terra doubles available magnetic field strength
“Moonshot” goal: Spread success to patients in half the time

October 10

When patients wrongly report drug allergies, doctors use inferior drugs, study finds
While restrictions are increasing, a third of plans impose none
“Unfortunate” outcome in phase 3 JUNIPER trial of abemaciclib
Investigational peptide vaccine induces attack on various cancers
Company considering sale or spin-off of multibillion-dollar OTC business

October 9

One-time treatment eases pain for 12 weeks
Device targets moderate-to-severe central sleep apnea
Device billed as smallest, lightest responsive therapy for drug-resistant epilepsy
Potential new indication addresses EGFR mutation-positive NSCLC

October 6

Cobas Zika test is made by Roche Molecular Systems

October 5

New trial ordered in dispute between Amgen and Sanofi/Regeneron
Rapid testing approach may help speed effective treatment
First human trial shows progress toward preventing infections

October 4

Two formulations of MS drug earn Teva more than $4 billion

October 3

Vaccine uses proteins found in core of virus rather than on its surface
The inhaled therapy treats fungal infections in the lungs
Presentation of the treatment may be as important as the treatment itself

Pages